Key result
Multistep care from testing to laparoscopic resection optimizes pheochromocytoma outcomes and prevents recurrence.
Answers are grounded in this paper and cite their sources.
Pheochromocytomas are catecholamine-producing tumors presenting with various clinical symptoms, but mostly with headache, sweating, palpitations and hypertension. If not properly diagnosed, secretion of catecholamines may lead to fatal cardiovascular consequences. Biochemical testing for pheochromocytoma should be performed not only in symptomatic subjects or in subjects with adrenal incidentaloma but also in subjects with a genetic predisposition for pheochromocytoma (multiple endocrine neoplasia type 2, Von Hippel-Lindau (VHL) syndrome, neurofibromatosis type 1 (NF 1)and mutations of succinate dehydrogenase (SDH) genes). Once a pheochromocytoma is proven, computed tomography (CT), magnetic resonance imaging (MRI) and functional imaging with [(123)I]-MIBG may be used for tumor localization. Adequate medical pre-treatment is essential for successful operation which is performed in most cases by laparoscopy. After tumor removal, further follow-up is necessary due to possible recurrence. Although prognosis after tumor resection is excellent, a significant proportion of pheochromocytomas recur, some as metastases. Thus, appropriate follow-up is mandatory.
No takes yet. Share an insight, caveat, or question.
Zelinka et al. (2007) conducted a review in Pheochromocytoma. Biochemical testing, imaging localization, medical pre-treatment, laparoscopic resection, and long-term follow-up are essential for managing pheochromocytoma and preventing recurrence.
Synapse has enriched 10 related papers. Consider them for comparative context: